Short answer
IRONWOOD PHARMACEUTICALS INC (IRWD) filed an 8-K current report with the SEC on May 13, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). CFO Gregory Martini resigning effective May 15, 2026, with no financial-reporting disagreement disclosed.
IRONWOOD PHARMACEUTICALS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- CFO Gregory Martini resigning effective May 15, 2026, with no financial-reporting disagreement disclosed
- Controller and Chief Accounting Officer Ronald Silver, 44, appointed interim CFO and principal financial officer
- Silver brings Ironwood tenure since June 2018 and prior accounting leadership experience
- Interim CFO transition creates near-term investor focus on permanent CFO search and financial reporting continuity
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other IRONWOOD PHARMACEUTICALS INC 8-K filings
Get the next IRWD 8-K as it lands
Follow IRWD for push alerts, or ask the research agent what this filing means.